Ammonia promotes the proliferation of bone marrow-derived mesenchymal stem cells by regulating the Akt/mTOR/S6k pathway

Abstract

Ammonia plays an important role in cellular metabolism. However, ammonia is considered a toxic product. In bone marrow-derived mesenchymal stem cells, multipotent stem cells with high expression of glutamine synthetase (GS) in bone marrow, ammonia and glutamate can be converted to glutamine via glutamine synthetase activity to support the proliferation of MSCs. As a major nutritional amino acid for biosynthesis, glutamine can activate the Akt/mTOR/S6k pathway to stimulate cell proliferation. The activation of mTOR can promote cell entry into S phase, thereby enhancing DNA synthesis and cell proliferation. Our studies demonstrated that mesenchymal stem cells can convert the toxic waste product ammonia into nutritional glutamine via GS activity. Then, the Akt/mTOR/S6k pathway is activated to promote bone marrow-derived mesenchymal stem cell proliferation. These results suggest a new therapeutic strategy and potential target for the treatment of diseases involving hyperammonemia.

References

[1] Mariño G, Kroemer G. Ammonia: A diffusible factor released by proliferating cells that induces autophagy. Sci. Signal., 2010, 3: pe19

[2] Luo C et al. Ammonia drives dendritic cells into dysfunction. J. Immunol. (Baltim., Md.: 1950), 2014, 193: 1080-1089

[3] Bharat A et al. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci. Transl. Med., 2015, 7: 284re3

[4] Polletta L et al. SIRT5 regulation of ammonia-induced autophagy and mitophagy. Autophagy, 2015, 11: 253-270

[5] Eng CH, Yu K, Lucas J, White E, Abraham RT. Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci. Signal., 2010, 3: ra31

[6] Spinelli JB et al. Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass. Science, 2017, 358: 941-946

[7] Newsholme P et al. Glutamine and glutamate as vital metabolites. Braz. J. Med. Biol. Res., 2003, 36: 153-163

[8] Laxman S, Sutter BM, Shi L, Tu BP. Npr2 inhibits TORC1 to prevent inappropriate utilization of glutamine for biosynthesis of nitrogen-containing metabolites. Sci. Signal., 2014, 7: ra120

[9] Yuan L et al. Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway. Endocr.-Relat. cancer, 2015, 22: 577-591

[10] Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell, 2017, 168: 960-976

[11] Jewell JL, Guan K-L. Nutrient signaling to mTOR and cell growth. Trends biochemical Sci., 2013, 38: 233-242

[12] Nguyen JT et al. Mammalian EAK-7 activates alternative mTOR signaling to regulate cell proliferation and migration. Sci. Adv., 2018, 4: eaao5838

[13] Yang HW, Chung M, Kudo T, Meyer T. Competing memories of mitogen and p53 signalling control cell-cycle entry. Nature, 2017, 549: 404-408

[14] Shingo Niimi, K. K. Cyclin D2 Promotes the Proliferation of Human Mesenchymal Stem Cells. J. Bone Marrow Res. 02; https://doi.org/10.4172/2329-8820.1000136 (2014).

[15] Jiang Y et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002, 418: 41-49

[16] Méndez-Ferrer S et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature, 2010, 466: 829-834

[17] Tardito S et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat. Cell Biol., 2015, 17: 1556-1568

[18] DeBerardinis RJ et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA, 2007, 104: 19345-19350

[19] Starc N et al. Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency. Sci. Rep., 2017, 7

[20] Zhu H et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc., 2010, 5: 550-560

[21] Zaytouni T et al. Critical role for arginase 2 in obesity-associated pancreatic cancer. Nat. Commun., 2017, 8

[22] Lee MN et al. Elevated extracellular calcium ions promote proliferation and migration of mesenchymal stem cells via increasing osteopontin expression. Exp. Mol. Med., 2018, 50: 142

[23] Li Y-Q, Wong CS. Effects of p21 on adult hippocampal neuronal development after irradiation. Cell death Discov., 2018, 4

[24] Raju K et al. Regulation of brain glutamate metabolism by nitric oxide and S-nitrosylation. Sci. Signal., 2015, 8: ra68

[25] Zhai Y et al. Activation of the TOR signalling pathway by glutamine regulates insect fecundity. Sci. Rep., 2015, 5

[26] Fan Q-W et al. EGFR signals to mTOR through PKC and independently of Akt in glioma. Sci. Signal., 2009, 2: ra4

[27] Ryu JM, Lee MY, Yun SP, Han HJ. Zinc chloride stimulates DNA synthesis of mouse embryonic stem cells: Involvement of PI3K/Akt, MAPKs, and mTOR. J. Cell. Physiol., 2009, 218: 558-567

[28] Lee MM et al. Characterization of Mandibular Bone in a Mouse Model of Chronic Kidney Disease. J. Periodontol., 2010, 81: 300-309

[29] Alexandrou C et al. Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes. Sci. Rep., 2018, 8

[30] Klejman A et al. Mechanisms of ammonia-induced cell death in rat cortical neurons: Roles of NMDA receptors and glutathione. Neurochemistry Int., 2005, 47: 51-5 7

[31] Chen R et al. Role of glutamine synthetase in angiogenesis beyond glutamine synthesis. Nature, 2018, 561: 63-69

[32] Dai J, Fu Y, Zeng Y, Li S, Qin Yin Z. Improved retinal function in RCS rats after suppressing the over-activation of mGluR5. Sci. Rep., 2017, 7

[33] Fingar DC et al. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol. Cell. Biol., 2004, 24: 200-216

[34] Chatterjee, A. Control of Cell Cycle Progression by mTOR. Dissertations & Theses - Gradworks (2015).

[35] Swamy M et al. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy. Nat. Immunol., 2016, 17: 712-720

[36] Chen DS, Mellman I. Elements of cancer immunity and the cancer-immune set point. Nature, 2017, 541: 321-330

[37] Kim KH, Lee M-S. Autophagy—a key player in cellular and body metabolism. Nat. Rev. Endocrinol., 2014, 10: 322-337

[38] Ren NSX et al. Haploinsufficiency of SIRT1 enhances glutamine metabolism and promotes cancer development. Curr. Biol., 2017, 27: 483-494

[39] Michalak KP, Mackowska-Kedziora A, Sobolewski B, Wozniak P. Key roles of glutamine pathways in reprogramming the cancer metabolism. Oxid. Med. Cell. Longev., 2015, 2015: 964321

[40] Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends biochemical Sci., 2010, 35: 427-433

[41] Zhou H et al. Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro. Sci. Rep., 2015, 5

Funding

National Natural Science Foundation of China (National Science Foundation of China)(No. 81602492)